- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05710822
QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study (peQasus)
January 25, 2023 updated by: Christian-H. Heeger, MD, University of Luebeck
Very High-Power Short-duration Ablation Utilizing the QDOT Micro Ablation Catheter for Pulmonary Vein Isolation - A Multicenter Study.
PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI.
Data of at least 300 patients with QDOT based PVI will be collected.
All data will be evaluated after anonymization.
Primary endoints are efficacy and safety.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christian-Hendrik Heeger, MD
- Phone Number: 004945150075293
- Email: christian.heeger@gmx.net
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Afib patients with indication to pulmonary vein isolation
Description
Inclusion Criteria:
- Suitable for PVI
Exclusion Criteria:
- Non suitable for PVI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of the procedure
Time Frame: Periprocedural
|
Acute PVI
|
Periprocedural
|
Saftey (Cardiac tamponade)
Time Frame: Periprocedural
|
Periprocedural complications (occurence of cardiac tamponade)
|
Periprocedural
|
Safety (Stroke)
Time Frame: Periprocedural
|
Periprocedural complications (occurence of stroke)
|
Periprocedural
|
Safety (Bleeding)
Time Frame: Periprocedural
|
Periprocedural complications (occurence of puncture site bleeding)
|
Periprocedural
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedure time
Time Frame: Periprocedural
|
Periprocedural
|
|
LA dwelling time
Time Frame: Periprocedural
|
Periprocedural
|
|
First pass isolation
Time Frame: Periprocedural
|
Periprocedural
|
|
12 months follow-up
Time Frame: 91 days - 12 months after the procedure
|
Occurence of aftrial fibrillation or atrial tachycardia >30 Seconds between 91 days and 12 months of follow-up
|
91 days - 12 months after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christian-Hendrik Heeger, MD, Department of Rhythmology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 31, 2023
Primary Completion (ANTICIPATED)
June 30, 2023
Study Completion (ANTICIPATED)
June 30, 2023
Study Registration Dates
First Submitted
January 17, 2023
First Submitted That Met QC Criteria
January 25, 2023
First Posted (ACTUAL)
February 2, 2023
Study Record Updates
Last Update Posted (ACTUAL)
February 2, 2023
Last Update Submitted That Met QC Criteria
January 25, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- peQasus study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
St. George's Hospital, LondonRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited Kingdom
-
R-PharmFSBI "National Medical Research Center of Cardiology named after academician...CompletedAtrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationRussian Federation
Clinical Trials on pulmonary vein isolation
-
University of LeipzigRecruiting
-
University Medical Center GroningenBoston Scientific CorporationNot yet recruiting
-
Instituto de investigación e innovación biomédica...Active, not recruitingAtrial Fibrillation, PersistentSpain
-
Brigham and Women's HospitalBoston Scientific CorporationNot yet recruitingAtrial Fibrillation ParoxysmalUnited States
-
Hospital General Universitario de AlicanteNot yet recruiting
-
AtriCure, Inc.Active, not recruitingAtrial FibrillationUnited States
-
Asklepios proresearchCompletedAtrial Fibrillation | TachycardiaGermany
-
Diagram B.V.CompletedParoxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Out of Range Hypertension | Signs of Sympathetic OverdriveSpain, Netherlands
-
Haukeland University HospitalUniversity Hospital of North Norway; St. Olavs HospitalCompletedPersistent Atrial FibrillationNorway
-
Hospital Clinic of BarcelonaRecruiting